Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis

Infection and Immunity

Volumn 75, Issue 4, 2007, Pages 1895-1903

  Tessier, Jeffrey ^a,d   Green, Candace ^a   Padgett, Diana ^b   Zhao, Wei ^c   Schwartz, Lawrence ^c   Hughes, Molly ^a   Hewlett, Erik ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; APREPITANT; BACTERIAL ANTIGEN; BACTERIAL TOXIN; CELECOXIB; CROMOGLYCATE DISODIUM; CYCLIC AMP; CYCLOOXYGENASE 2 INHIBITOR; EDEMA TOXIN; HISTAMINE; INDOMETACIN; MEPYRAMINE; NEUROKININ; NEUROKININ 1 RECEPTOR ANTAGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; PROTECTIVE ANTIGEN; SPANTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; DISEASE MODEL; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; EVALUATION; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; CAPILLARY PERMEABILITY; CELL DEGRANULATION; CELL LINE; DISEASE MODELS, ANIMAL; EDEMA; ENZYME INHIBITORS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; INDOMETHACIN; INJECTIONS, INTRADERMAL; MAST CELLS; MORPHOLINES; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDINS; PYRAZOLES; PYRILAMINE; RABBITS; RECEPTORS, NEUROKININ-1; SUBSTANCE P; SULFONAMIDES; TACHYKININS;

EID: 34147160193     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01632-06     Document Type: Article

References (68)

1. Alton, E. W., and A. A. Norris. 1996. Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma. J. Allergy Clin. Immunol. 98:S102-S105.
2. Annunziata, P., C. Cioni, R. Santonini, and E. Paccagnini. 2002. Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium. J. Neuroimmunol. 131:41-49.
3. Bae, S. J., Y. Matsunaga, M. Takenaka, Y. Tanaka, Y. Hamazaki, K. Shimizu, and I. Katayama. 2002. Substance P induced preprotachykinin-a mRNA, neutral endopeptidase mRNA and substance P in cultured normal fibroblasts. Int. Arch. Allergy Immunol. 127:316-321.
4. Bardelli, C., G. Gunella, F. Varsaldi, P. Balbo, E. Del Boca, I. S. Bernardone, A. Amoruso, and S. Brunelleschi. 2005. Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway. Br. J. Pharmacol. 145:385-396.
5. Bonuccelli, G., F. Sotgia, P. G. Frank, T. M. Williams, C. J. de Almeida, H. B. Tanowitz, P. E. Scherer, K. A. Hotchkiss, B. I. Terman, B. Rollman, A. Alileche, J. Brojatsch, and M. P. Lisanti. 2005. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection. Am. J. Physiol. Cell Physiol. 288:C1402-C1410.
6. Bradley, K. A., J. Mogridge, M. Mourez, R. J. Collier, and J. A. Young. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
7. Campos, M. M., and J. B. Calixto. 2000. Neurokinin mediation of edema and inflammation. Neuropeptides 34:314-322.
8. Church, M. K., S. el Lati, and J. P. Caulfield. 1991. Neuropeptide-induced secretion from human skin mast cells. Int. Arch. Allergy Appl. Immunol. 94:310-318.
9. Coffey, R. G. 1992. Effects of cyclic nucleotides on granulocytes. Immunol. Ser. 57:301-338.
10. Costa, S. K., L. M. Yshii, R. N. Poston, M. N. Muscara, and S. D. Brain. 2006. Pivotal role of endogenous tachykinins and the NK1 receptor in mediating leukocyte accumulation, in the absence of oedema formation, in response to TNFalpha in the cutaneous microvasculature. J. Neuroimmunol. 171:99-109.
11. Craig, J. P. 1965. A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature 207:614-616.
12. Crawford, M. A., C. V. Aylott, R. W. Bourdeau, and G. M. Bokoch. 2006. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J. Immunol. 176:7557-7565.
13. Cromartie, W. J., W. L. Bloom, and D. W. Watson. 1947. Studies on infection with Bacillus anthracis. I. A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J. Infect. Dis. 80:1-13.
14. Crossman, D. C., M. R. Dashwood, G. W. Taylor, R. Wellings, and R. W. Fuller. 1993. Sodium cromoglycate: evidence of tachykinin antagonist activity in the human skin. J. Appl. Physiol. 75:167-172.
15. Cunningham, K., D. B. Lacy, J. Mogridge, and R. J. Collier. 2002. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc. Natl. Acad. Sci. USA 99:7049-7053.
16. Dianzani, C., M. Collino, G. Lombardi, G. Garbarino, and R. Fantozzi. 2003. Substance P increases neutrophil adhesion to human umbilical vein endothelial cells. Br. J. Pharmacol. 139:1103-1110.
17. Driver, A. G., and S. J. Mustafa. 1987. Correlation of histamine H1 receptor function and [3H]mepyramine binding in porcine tracheal tissue. Eur. J. Pharmacol. 139:287-295.
18. Drum, C. L., S. Z. Yan, J. Bard, Y. Q. Shen, D. Lu, S. Soelaiman, Z. Grabarek, A. Bohm, and W. J. Tang. 2002. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415:396-402.
19. Ehringer, W. D., M. J. Edwards, and F. N. Miller. 1996. Mechanisms of alpha-thrombin, histamine, and bradykinin induced endothelial permeability. J. Cell. Physiol. 167:562-569.
20. Firoved, A. M., G. F. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. F. Wiggins, E. M. McNally, W. J. Tang, and S. H. Leppla. 2005. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167:1309-1320.
21. Flamand, N., M. Surette, S. Picard, S. Bourgoin, and P. Borgeat. 2002. Cyclic AMP-mediated inhibition of 5-lipoxygenase translocation and leukotriene biosynthesis in human neutrophils. Mol. Pharmacol. 62:250-256.
22. Folkesson, H. G., M. A. Matthay, C. A. Hebert, and V. C. Broaddus. 1995. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J. Clin. Investig. 96:107-116.
23. Gordon, V. M., W. W. Young, Jr., S. M. Lechler, M. C. Gray, S. H. Leppla, and E. L. Hewlett. 1989. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 264:14792-14796.
24. Gozes, Y., M. Moayeri, J. F. Wiggins, and S. H. Leppla. 2006. Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect. Immun. 74:1266-1272.
25. Grinberg, L. M., F. A. Abramova, O. V. Yampolskaya, D. H. Walker, and J. H. Smith. 2001. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 14:482-495.
26. Guidi-Rontani, C., M. Weber-Levy, M. Mock, and V. Cabiaux. 2000. Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell. Microbiol. 2:259-264.
27. Henderson, W. R., Jr. 1994. The role of leukotrienes in inflammation. Ann. Intern. Med. 121:684-697.
28. Hoover, D. L., A. M. Friedlander, L. C. Rogers, I.-K. Yoon, R. L. Warren, and A. S. Cross. 1994. Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cyclic AMP. Infect. Immun. 62:4432-4439.
29. Irie, K., E. Fujii, H. Ishida, K. Wada, T. Suganuma, T. Nishikori, T. Yoshioka, and T. Muraki. 2001. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin. Br. J. Pharmacol. 133:237-242.
30. Issekutz, A. 1981. Vascular responses during acute neutrophilic inflammation: their relationship to in vivo neutrophil emigration. Lab. Investig. 45: 435-441.
31. Jelenko, C., III, W. I. Smulyan, and M. L. Wheeler. 1967. Studies in burns: IV. The relationship of eschar water content to eschar water transmissivity. Ann. Surg. 166:278-286.
32. Kambe, N., M. Kambe, J. P. Kochan, and L. B. Schwartz. 2001. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood 97:2045-2052.
33. Kasznicki, J., and A. Wiktorowska-Owczarek. 2001. Effects of indomethacin on hemodynamic parameters after intravenous administration of propranolol and enalaprilat in rabbits. Pol. J. Pharmacol. 53:487-493.
34. Kingston, W. P., and M. W. Greaves. 1985. Actions of prostaglandin E2 metabolites on skin microcirculation. Agents Actions 16:13-14.
35. Le Filliatre, G., S. Sayah, V. Latournerie, J. Renaud, M. Finet, and R. Hanf. 2001. Cyclo-oxygenase and lipoxygenase pathways in mast cell dependent-neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve. Br. J. Pharmacol. 132:1581-1589.
36. Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-3166.
37. Li, Y., S. D. Douglas, D. E. Pleasure, J. Lai, C. Guo, P. Bannerman, M. Williams, and W. Ho. 2003. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression. J. Neurosci. Res. 71:559-566.
38. Lin, J. H. 1991. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations. Clin. Pharmacokinet. 20:218-236.
39. Linnik, M. D., and M. A. Moskowitz. 1989. Identification of immunoreactive substance P in human and other mammalian endothelial cells. Peptides 10:957-962.
40. Maggi, C. A. 1997. The effects of tachykinins on inflammatory and immune cells. Regul. Pept. 70:75-90.
41. Malik, A., J. Lynch, and J. Cooper. 1989. Endothelial barrier function. J. Investig. Dermatol. 93:62S-67S.
42. Milne, J. C., S. R. Blanke, P. C. Hanna, and R. J. Collier. 1995. Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus. Mol. Microbiol. 15:661-666.
43. O'Brien, J., A. Friedlander, T. Dreier, J. Ezzell, and S. Leppla. 1985. Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47:306-310.
44. Ollivier, V., G. Parry, R. Cobb, D. de Prost, and N. Mackman. 1996. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic and endothelial cells. J. Biol. Chem. 271:20828-20835.
45. Paccani, S. R., F. Tonello, R. Ghittoni, M. Natale, L. Muraro, M. M. D'Elios, W. J. Tang, C. Montecucco, and C. T. Baldari. 2005. Anthrax toxins suppress T lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 201:325-331.
46. Pascual, D. W., and K. L. Bost. 1990. Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. Immunology 71:52-56.
47. Patel, L., and C. Lindley. 2003. Aprepitant - a novel NK1-receptor antagonist. Expert Opin. Pharmacother. 4:2279-2296.
48. Riske, F., J. Hakimi, M. Mallamaci, M. Griffin, B. Pilson, N. Tobkes, P. Lin, W. Danho, J. Kochan, and R. Chizzonite. 1991. High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. J. Biol. Chem. 266:11245-11251.
49. Rivera, J., and A. M. Gilfillan. 2006. Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 117:1214-1225.
50. Rosenshein, M. S., T. H. Price, and D. C. Dale. 1979. Neutropenia, inflammation, and the kinetics of transfused neutrophils in rabbits. J. Clin. Investig. 64:580-585.
51. Sandoval, R., A. B. Malik, T. Naqvi, D. Mehta, and C. Tiruppathi. 2001. Requirement for Ca2+ signaling in the mechanism of thrombin-induced increase in endothelial permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L239-L247.
52. Scholzen, T. E., M. Steinhoff, P. Bonaccorsi, R. Klein, S. Amadesi, P. Geppetti, B. Lu, N. P. Gerard, J. E. Olerud, T. A. Luger, N. W. Bunnett, E. F. Grady, C. A. Armstrong, and J. C. Ansel. 2001. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J. Immunol. 166:1285-1291.
53. Schwartz, L. B., R. A. Lewis, D. Seldin, and K. F. Austen. 1981. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 126:1290-1294.
54. Scobie, H., J. Rainey, K. Bradley, and J. Young. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100:5170-5174.
55. Shichijo, M., N. Inagaki, M. Kimata, I. Serizawa, H. Saito, and H. Nagai. 1999. Role of cyclic 3′,5′-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured mast cells. J. Allergy Clin. Immunol. 103:S421-S428.
56. Simmons, D. L., R. M. Botting, and T. Hla. 2004. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56: 387-437.
57. Spencer, R. 2003. Bacillus anthracis. J. Clin. Pathol. 56:182-187.
58. Staddon, J., and T. Hirase. 1999. Tight junctions and adherens junctions in endothelial cells: structure and regulation, p. 109-124. In J. Pearson (ed.), Vascular adhesion molecules and inflammation. Birkhäuser Verlag, Basel, Switzerland.
59. Sugio, K., and J. W. Daly. 1983. Effect of forskolin on alterations of vascular permeability induced with bradykinin, prostaglandin E1, adenosine, histamine and carrageenin in rats. Life Sci. 33:65-73.
60. Tang, H. B., A. Inoue, M. Iwasa, I. Hide, and Y. Nakata. 2006. Substance P release evoked by capsaicin or potassium from rat cultured dorsal root ganglion neurons is conversely modulated with bradykinin. J. Neurochem. 97:1412-1418.
61. Teixeira, M. M., T. J. Williams, and P. G. Hellewell. 1993. E-type prostaglandins enhance local oedema formation and neutrophil accumulation but suppress eosinophil accumulation in guinea-pig skin. Br. J. Pharmacol. 110: 416-422.
62. Tournier, J. N., A. Quesnel-Hellmann, J. Mathieu, C. Montecucco, W. J. Tang, M. Mock, D. R. Vidal, and P. L. Goossens. 2005. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J. Immunol. 174:4934-4941.
63. Wade, B. H., G. G. Wright, E. L. Hewlett, S. H. Leppla, and G. L. Mandell. 1985. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils (42078). Proc. Soc. Exp. Biol. Med. 179:159-162.
64. Wang, K., K. Tarakji, Z. Zhou, M. Zhang, F. Forudi, X. Zhou, A. T. Koki, M. E. Smith, B. T. Keller, E. J. Topol, A. M. Lincoff, and M. S. Penn. 2005. Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model. J. Cardiovasc. Pharmacol. 45:61-67.
65. Wright, G., and G. Mandell. 1986. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J. Exp. Med. 164: 1700-1709.
66. Yoshimoto, T., C. Yokoyama, K. Ochi, S. Yamamoto, Y. Maki, Y. Ashida, S. Terao, and M. Shiraishi. 1982. 2,3,5-Trimethyl-6-(12-hydroxy-5,10- dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim. Biophys. Acta 713:470-473.
67. Zaucha, G., M. Pitt, J. Estep, B. Ivins, and A. M. Friedlander. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122:982-992.
68. Zhao, W., C. L. Kepley, P. A. Morel, L. M. Okumoto, Y. Fukuoka, and L. B. Schwartz. 2006. Fc gamma RIIa, not Fc gamma RIIb, is constitutively and functionally expressed on skin-derived human mast cells. J. Immunol. 177: 694-701.